NetworkNewsBreaks – PotNetwork Holding, Inc. (PO
Post# of 371
PotNetwork Holding, Inc. (OTC: POTN) this morning announced its appointment of Dr. Michael McKenzie, an industry-leading physician, to its advisory board, effectively furthering its strategy centered on formulating, producing and marketing a spectrum of exclusive and diversely targeted cannabidiol blends. As noted in this morning’s update, Dr. McKenzie has positioned himself at the forefront of the medical marijuana industry by gaining a keen understanding of cannabis and its specific impact on a number of unique illnesses. “Dr. McKenzie is going to be an invaluable addition to our team. He has already been very instrumental in providing valuable guidance, and has proved to be a knowledgeable and influential contributor,” Dr. Richard Goulding, CEO of PotNetwork, stated in the news release. “We are very pleased with his addition to our team. In the Company’s effort to fortify its presence in the industry with a specialized focus, management has resolved to enhance the Board of Advisors with industry pioneers who can be instrumental in directing the Company’s endeavors to develop targeted formulas designed to deliver results for a diverse spectrum of challenges that studies reveal CBD can help.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer